Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Operational Update June 4, 2025 Next Post Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines June 4, 2025 Related Posts Ian Rodger Appointed Managing Director July 1, 2025 South Harz Potash Limited July 1, 2025 Equity Metals July 1, 2025